| scholarly article | Q13442814 |
| P2093 | author name string | Nesrin Karamustafalioglu | |
| Kaan Kora | |||
| Mete Saylan | |||
| Cengiz Akkaya | |||
| Nesrin Tomruk | |||
| Timucin Oral | |||
| Aziz Yasan | |||
| P2860 | cites work | The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence | Q22241870 |
| Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| The longitudinal course of bipolar disorder. | Q33926833 | ||
| Novel treatments for bipolar disorder | Q34204347 | ||
| Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials. | Q34306608 | ||
| Clinical correlates of therapeutic response in bipolar disorder | Q34547113 | ||
| Is lithium still worth using? An update of selected recent research | Q34565672 | ||
| The role of novel antipsychotics in bipolar disorders. | Q34574169 | ||
| Bipolar disorders and the effectiveness of novel anticonvulsants. | Q34574175 | ||
| Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations | Q34631235 | ||
| Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 | ||
| Novel antipsychotics in bipolar and schizoaffective mania | Q35760251 | ||
| Polytherapy in bipolar disorder | Q36361982 | ||
| Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. | Q42164355 | ||
| Quetiapine alone and added to a mood stabilizer for serious mood disorders | Q42662545 | ||
| The economic burden of bipolar disease. | Q43606011 | ||
| Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
| Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 | ||
| How real are patients in placebo-controlled studies of acute manic episode? | Q44910824 | ||
| Demographic and clinical characteristics of individuals in a bipolar disorder case registry | Q45027844 | ||
| Dimensions of depression, mania and psychosis in the general population | Q48563372 | ||
| Time to remission and relapse after the first hospital admission in severe bipolar disorder. | Q51933587 | ||
| The likelihood of recurrence in bipolar affective disorder: the importance of episode recency. | Q52017623 | ||
| Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. | Q52900826 | ||
| Subtypes of manic episodes according to ICD-10—prediction of time to remission and risk of relapse | Q60643567 | ||
| Recovery from episodes during the course of affective disorder: a case-register study | Q73051310 | ||
| [Reliability and validity of Turkish translation of Young Mania Rating Scale] | Q73497464 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 114-119 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Primary Care Companion to the Journal of Clinical Psychiatry | Q15751574 |
| P1476 | title | Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study | |
| P478 | volume | 10 |
| Q41474674 | Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors |
| Q43119910 | Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics. |
| Q86485574 | Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort |
Search more.